Concert Pharmaceuticals, Inc. EPS - Earnings per Share 2014-2022 | CNCE
Concert Pharmaceuticals, Inc. eps - earnings per share from 2014 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Concert Pharmaceuticals, Inc. Annual EPS |
| 2021 |
$-2.33 |
| 2020 |
$-2.40 |
| 2019 |
$-3.29 |
| 2018 |
$-2.40 |
| 2017 |
$4.06 |
| 2016 |
$-2.28 |
| 2015 |
$1.09 |
| 2014 |
$-2.00 |
| 2013 |
$-4.99 |
| 2012 |
$-16.15 |
| 2011 |
$-9.66 |
| Concert Pharmaceuticals, Inc. Quarterly EPS |
| 2022-09-30 |
$-0.58 |
| 2022-06-30 |
$-0.59 |
| 2022-03-31 |
$-1.03 |
| 2021-12-31 |
$-1.04 |
| 2021-09-30 |
$-0.78 |
| 2021-06-30 |
$0.16 |
| 2021-03-31 |
$-0.67 |
| 2020-12-31 |
$-0.69 |
| 2020-09-30 |
$-0.60 |
| 2020-06-30 |
$-0.41 |
| 2020-03-31 |
$-0.70 |
| 2019-12-31 |
$-0.86 |
| 2019-09-30 |
$-0.72 |
| 2019-06-30 |
$-0.78 |
| 2019-03-31 |
$-0.93 |
| 2018-12-31 |
$-0.90 |
| 2018-09-30 |
$-0.74 |
| 2018-06-30 |
$-0.57 |
| 2018-03-31 |
$-0.19 |
| 2017-12-31 |
$-0.20 |
| 2017-09-30 |
$5.44 |
| 2017-06-30 |
$-0.58 |
| 2017-03-31 |
$-0.60 |
| 2016-12-31 |
$-0.54 |
| 2016-09-30 |
$-0.51 |
| 2016-06-30 |
$-0.60 |
| 2016-03-31 |
$-0.63 |
| 2015-12-31 |
$0.16 |
| 2015-09-30 |
$-0.39 |
| 2015-06-30 |
$1.80 |
| 2015-03-31 |
$-0.48 |
| 2014-12-31 |
$-0.36 |
| 2014-09-30 |
$-0.43 |
| 2014-06-30 |
$-0.45 |
| 2014-03-31 |
$-0.76 |
| 2013-12-31 |
$2.06 |
| 2013-09-30 |
$-5.59 |
| 2013-06-30 |
$0.00 |
| 2013-03-31 |
$-1.46 |
